StrongBox Wealth’s GSK GSK Stock Holding History

StrongBox Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.06K	Buy	+22	New	+$1.12K	﹤0.01%	270

Other funds holding GSK

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.34B AUM 13.98% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

StrongBox Wealth's GSK Position: Q3 2026 in Review

StrongBox Wealth opened a new position in GSK (GSK) in Q3 2026: 22 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #270 among its holdings.

520 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

StrongBox Wealth held 22 shares of GSK worth $1.06K as of Q3 2026.
GSK was a new StrongBox Wealth position in Q3 2026.
GSK made up ﹤0.01% of StrongBox Wealth's portfolio in Q3 2026, its #270 holding.
520 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on StrongBox Wealth's 13F filing for Q3 2026, filed 2 Nov 2026.